4Merati K, said Siadaty M, Andea A0 et al. Expression of inflammatory modulator COX-2 in pancreatic ductal adenocarcinoma and its relationship to panthologic and clinical parameters. Am J Clin Oncol, 2001, 24:447-452.
5Husain SS, Szabo IL, Tarnawski AS. NSAID inhibition of GI cancer growth., clinical implications and molecular mechanisms of action. Am J Gastroenterol, 2002, 97:542-543.
6Anderson KE, Johnson TW, Lazovich D, et al. Association between nonsteroidal anti-inflammatory drugs use and the incidence of pancreatic cancer. J Natl Cancer Inst, 2002, 94:1168-1171.
7Greenlee RT, Murray T, Bolden S, et al. Cancer statistics.2000, CA Cancer J Clin, 2000, 50:7-33.
8WANG L, YANG GH, LU XH, et al. Pancreatic cancer mortality in China,1991 - 2000. World J of Gastroenterol,
9LU XH, XU T, QIAN JM, et al. Detecting K-ras and p53 gene mutation from stool and pancreatic juice for diagnosis of early pancreatic cancer. Chin-Med-J (Engl), 2002, 115 : 1632-1636.
10Heldin CH, Miyazono K, ten Dijka P. TGF-β signaling from cell membrane to nucleus.through Smad proteins. Nature,1997, 390:465-471.
